Impact of Obesity on Atrial Fibrillation Recurrence Following Stand-Alone Cox Maze IV Procedure.
Robert M MacGregorAli J KhiabaniNadia H BakirMeghan O KellySamuel C PerezHersh S ManiarRichard B SchuesslerMarc R MoonSpencer J MelbyRalph J DamianoPublished in: Innovations (Philadelphia, Pa.) (2021)
As opposed to catheter ablation, obesity did not adversely impact the short and long-term outcomes of stand-alone surgical ablation with CMP-IV, and BMI was not a predictor of AF recurrence. Additionally, there was no significant increase in major complications in obese patients.
Keyphrases
- catheter ablation
- atrial fibrillation
- obese patients
- weight loss
- bariatric surgery
- left atrial
- weight gain
- insulin resistance
- left atrial appendage
- metabolic syndrome
- oral anticoagulants
- roux en y gastric bypass
- high fat diet induced
- gastric bypass
- type diabetes
- direct oral anticoagulants
- heart failure
- free survival
- body mass index
- percutaneous coronary intervention
- adipose tissue
- minimally invasive
- skeletal muscle
- risk factors
- venous thromboembolism